Market Tracker

08/28 6:50am ET

Immunomedics Inc (NASDAQ:IMMU)

3.25
Data as of Aug 27
 -0.09 / -2.69%
Today’s Change
3.04
Today|||52-Week Range
7.35
-29.35%
Year-to-Date

Today’s Trading

Previous close3.34
Today’s open3.33
Day’s range-- - --
Volume787,836
Average volume (3 months)520,906
Market cap$311.0M
Dividend yield--
Data as of 08/27/2014

Growth & Valuation

Earnings growth (last year)-1,700.00%
Earnings growth (this year)-146.87%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-84.84%
P/E ratioNM
Price/Sales85.56
Price/Book7.48

Competitors

 Today’s
change
Today’s
% change
LMNSLumenis Ltd-0.03-0.33%
CLDNCelladon Corp+0.44+3.85%
ARDXArdelyx Inc+0.46+3.42%
EARSAuris Medical Holdin...+0.08+1.31%
Data as of 08/27/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$5.0M
Annual profit (last year)-$12.2M
Net profit margin-245.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts